| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |
Cell Growth & Differentiation, Vol 8, Issue 8 851-860, Copyright © 1997 by American Association of Cancer Research
ARTICLES |
PA Rehberger, KH Richter, D Schwartz, N Goldfinger, R Oskato, N Almog, F Marks and V Rotter
Department of Biochemistry of Tissue-specific Regulation, Deutsches Krebsforschungzentrum, Heidelberg, Germany.
In the present study, we investigated the role of p53 in the differentiation of epidermal keratinocyte cells. The interrelationship between p53 expression and the various stages of epidermal differentiation and the role of the COOH terminus of the p53 molecule in this process were determined by comparing the expression of the regularly spliced p53 (RSp53) molecule and that of the COOH-terminal alternatively spliced (ASp53) form. p53 mRNA distribution was studied by in situ analysis of frozen skin sections and by reverse transcription-PCR analysis of the various wild-type p53 forms expressed in neonatal skin cell fractions separated by Percoll gradient. p53 protein levels were measured by fluorescence-activated cell sorting analysis and immunohistochemistry, using antibodies that recognize either the COOH terminus of RSp53 or ASp53. The results show that although less mature keratinocyte cells predominantly express the RSp53 form, the more mature cells preferentially express the ASp53 form. Therefore, it is possible that the two p53 forms are associated with different functions required at the various stages of keratinocyte differentiation. The results suggest that the COOH-terminal domain of the p53 molecule is important for its activity in the process of keratinocyte differentiation.
This article has been cited by other articles:
![]() |
K. J.-L. RILEY, L. A. CASSIDAY, A. KUMAR, and L. J. MAHER III Recognition of RNA by the p53 tumor suppressor protein in the yeast three-hybrid system. RNA, April 1, 2006; 12(4): 620 - 630. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Laverdiere, J. Beaudoin, and A. Lavigueur Species-specific regulation of alternative splicing in the C-terminal region of the p53 tumor suppressor gene Nucleic Acids Res., March 15, 2000; 28(6): 1489 - 1497. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A. Hall, S. J. Campbell, M. O'neill, D. J. Royston, K. Nylander, F. A. Carey, and N. M. Kernohan Expression of the p53 homologue p63{alpha} and {Delta}Np63{alpha} in normal and neoplasticcells Carcinogenesis, February 1, 2000; 21(2): 153 - 160. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. A. Tron, M. J. Trotter, L. Tang, M. Krajewska, J. C. Reed, V. C. Ho, and G. Li p53-Regulated Apoptosis Is Differentiation Dependent in Ultraviolet B-Irradiated Mouse Keratinocytes Am. J. Pathol., August 1, 1998; 153(2): 579 - 585. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |